Hypolaetin

Hypolaetin is a flavone aglycone (3',4',5,7-tetrahydroxyflavone) found in plants such as Sideritis species, exhibiting anti-inflammatory and gastroprotective effects primarily through inhibition of arachidonic acid metabolism and free radical scavenging. Its primary mechanism involves suppression of cyclooxygenase and lipoxygenase pathways, reducing prostaglandin and leukotriene synthesis without the gastric side effects associated with classical NSAIDs.

Origin & History

Hypolaetin is a flavone compound naturally found in Sideritis mugronensis, a plant traditionally known as 'mountain tea' in Mediterranean regions. It occurs primarily as hypolaetin-8-glucoside (glycoside form) in the plant and can be converted to its aglycone form through extraction and processing methods.

Historical & Cultural Context

Sideritis mugronensis has been used for centuries in Mediterranean traditional medicine, particularly in Spain and Greece, where it's consumed as 'mountain tea' for gastrointestinal complaints and inflammation. Traditional use involves whole plant infusions rather than isolated hypolaetin compounds.

Health Benefits

• Gastroprotective effects: Demonstrated prevention of cold-restraint-induced gastric lesions comparable to cimetidine in rat models (PMID: 6151974) - animal evidence only • Anti-inflammatory activity: Superior to phenylbutazone in acute inflammation models without causing gastric erosions (PMID: 6151974) - preclinical evidence • Prostaglandin modulation: Stimulates protective prostaglandin synthesis and inhibits degradation (PMID: 3839399) - mechanistic studies only • Potential ulcer prevention: Related flavonoids show efficacy in human peptic ulcer patients (PMC6253827) - indirect evidence • Mucosal protection: Enhanced prostacyclin release promotes gastric mucosal defense (PMID: 3839399) - animal studies only

How It Works

Hypolaetin inhibits both cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, reducing the biosynthesis of pro-inflammatory prostaglandins and leukotrienes derived from arachidonic acid. It also acts as a potent free radical scavenger due to its polyhydroxylated B-ring structure, particularly the 3',4'-catechol moiety, which donates hydrogen atoms to neutralize reactive oxygen species. Additionally, hypolaetin has been shown to modulate gastric mucosal protection potentially through preservation of prostaglandin E2-dependent cytoprotective mechanisms at the gastric epithelium.

Scientific Research

Research on hypolaetin is limited to preclinical animal studies, with no published human clinical trials identified. Key studies include rat models showing anti-inflammatory and gastroprotective effects (PMID: 6151974) and mechanistic research on prostaglandin pathways (PMID: 3839399). Human clinical evidence remains absent, representing a critical research gap.

Clinical Summary

Available evidence for hypolaetin is limited exclusively to preclinical animal studies, with no published human clinical trials identified to date. In rat models of cold-restraint-induced gastric ulceration, hypolaetin demonstrated gastroprotective efficacy comparable to the H2 blocker cimetidine (PMID: 6151974). Separate rodent acute inflammation models showed hypolaetin surpassed phenylbutazone in anti-inflammatory potency while avoiding the gastric erosions that phenylbutazone typically induces (PMID: 6151974 and related work). The overall evidence base is early-stage and animal-derived, making extrapolation to human clinical outcomes premature.

Nutritional Profile

Hypolaetin (5,7,8,3',4'-pentahydroxyflavone; C₁₅H₁₀O₇; MW 302.24 g/mol) is a naturally occurring flavone aglycone, not a nutritional food source per se but rather a bioactive polyphenolic compound found in trace quantities in select plant species. Key details: • Chemical class: Flavone (a subclass of flavonoids), structurally related to luteolin but with an additional hydroxyl group at the C-8 position on the A-ring. • Natural sources: Found in Sideritis species (ironwort/mountain tea), particularly Sideritis mugronensis and other Mediterranean Sideritis spp.; also reported in Bystropogon species and certain Lamiaceae family plants. Concentrations in dried Sideritis herba are typically in the range of 0.01–0.5% w/w depending on species, plant part, and extraction method. • Glycosidic forms: Commonly occurs as hypolaetin-8-glucoside (C₂₁H₂₀O₁₂; MW 464.38) in plant tissues, which undergoes partial hydrolysis to the aglycone during digestion. • Bioavailability: Like most polyhydroxylated flavones, oral bioavailability is expected to be low (estimated <5–10% based on structural analogs such as luteolin), limited by poor aqueous solubility, extensive Phase II conjugation (glucuronidation and sulfation in intestinal and hepatic tissues), and potential microbial metabolism in the colon. The 8-glucoside form may have modestly improved absorption compared to the free aglycone due to SGLT1-mediated intestinal uptake of the glycoside. • Key functional groups: Five free phenolic hydroxyl groups (positions 5, 7, 8, 3', 4') conferring strong radical-scavenging and metal-chelating capacity; the catechol moiety on the B-ring (3',4'-dihydroxy) and the pyrogallol-type arrangement on the A-ring (5,7,8-trihydroxy) contribute to high antioxidant potential (ORAC and DPPH activity generally superior to monohydroxylated flavones). • Caloric/macronutrient contribution: Negligible — consumed in microgram-to-low-milligram quantities from herbal tea infusions (e.g., a typical 200 mL Sideritis tea infusion may deliver approximately 0.5–5 mg total hypolaetin equivalents including glycosides). No meaningful protein, fat, carbohydrate, or fiber contribution. • No recognized vitamin or mineral content intrinsic to the isolated compound. • Solubility: Sparingly soluble in water (~0.1–0.5 mg/mL at 25°C); soluble in DMSO, methanol, and ethanol. Infusion in hot water as traditional herbal tea partially extracts the glycosidic forms.

Preparation & Dosage

No human dosages have been established due to absence of clinical trials. Animal studies used ED50 values of 57.3-68.0 mg/kg for gastroprotective effects. Traditional preparation involves herbal infusions of whole Sideritis plant material. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Quercetin, Kaempferol, Piperine, Phosphatidylcholine, Zinc-carnosine

Safety & Interactions

No human safety data or clinical toxicology studies for isolated hypolaetin have been published, making a definitive safety profile impossible to establish. Based on its COX and LOX inhibitory activity, theoretical interactions with anticoagulants such as warfarin, antiplatelet drugs, and other NSAIDs are plausible and warrant caution. Pregnancy and lactation safety is entirely unknown, and use should be avoided in those populations until data exist. Animal studies did not report gastric erosions at tested doses, suggesting a potentially favorable GI tolerability profile compared to phenylbutazone, but this has not been confirmed in humans.